Canada to Health Pros: All Finasteride Patients Should ‘Be Screened for Suicidal Ideation, Self-harm, and Depression’ Before Being Prescribed the Drug

Japanese disproportionality analysis of finasteride ADRs, meanwhile, shows completed suicides 270% higher than expected Jan. 28, 2024 Dear Friends: Canada is taking no chances vis-á-vis finasteride wreaking havoc on its citizens’ psyches. Pre-prescription edict Last week, drug-regulatory authority (DRA) Health Canada (HC), via its monthly Health Product InfoWatch bulletin, informed its nation’s healthcare professionals that: […]

51% of Dermatologists Believe Finasteride ‘May Cause’ Sexual Side Effects—but Only 18% Believe those ADRs May Persist, Says New Harvard Medical School Research

Pioneering PFS investigator Michael Irwig also finds that just 13% of respondents believe finasteride could cause depression, while 54% believe the drug is ‘unlikely’ or ‘very unlikely’ to do so Aug. 16, 2023 Dear Friends: Despite the fact that the finasteride product label has included depression and persistent loss of libido as possible side effects […]

Neuropsychiatric Side Effects for Finasteride Housed on FDA Database Show Disproportionate Safety Signals Compared to Control Meds—and a ‘Striking Increase in Suicides’—Says New Research

Following new safety review, Health Canada working with finasteride manufacturers to strengthen suicidality warning March 27, 2023 Dear Friends: Although the US Food and Drug Administration rarely mentions PFS, its database of side effects speaks volumes about the condition’s epidemiology. Out of control According to new research based in part on the agency’s Adverse Event […]

Study Used to Push Non-FDA-Approved Topical Finasteride Knocked by Top German Rx Journal

‘It is still unclear to what extent the lower systemic drug exposure translates into a lower risk of side effects,’ says Deutsche Apotheker Zeitung. ‘The limited number of patients makes it difficult to draw reliable conclusions.’ March 20, 2023 Dear Friends: Germany’s oldest and most widely read pharmaceutical journal has taken a deep dive into […]

UK Drug Regulatory Authority MHRA Investigating Finasteride Safety

Probe launched after tête-à-tête with French counterpart ANSM, whose ‘red box’ warning will be slapped on all finasteride 1 mg packaging next month March 5, 2023 Dear Friends: The British are coming—hopefully with a PFS-awareness program on par with that of the French. Dr. White does right According to a February 16 memo from Amelia […]

Topical Finasteride Could Precipitate PFS, Top German Rx Journal Warns

Stricken US college student corroborates red flag raised to 29,000 pharmacists Feb. 27, 2023 Dear Friends: Spraying finasteride on your scalp instead of ingesting it is no guarantee you won’t develop post-finasteride syndrome (PFS). So cautions Germany’s oldest and most widely read pharmaceutical journal. So, too, an American college senior who says his academic, social […]

France Orders ‘Red-Box’ Warning—and QR Code Linking to PFS-Awareness Dossier—Slapped on all Finasteride 1 mg Products by April

Dec. 4, 2022 Dear Friends: French PFS awareness is going high-tech. ANSM, the Gallic nation’s drug-regulatory authority (DRA), last week unveiled plans to add a so-called “red-box” warning—that includes a QR code—on all finasteride 1 mg products in 2023. Intended to “reinforce information on adverse effects” of Propecia and generics, the warning reads: This medication […]